All news

Enliven Therapeutics Director Sold Shares Worth Over $606K

Alpha Vantage · TradingView · · AI-summarised by FinFlash

A director at Enliven Therapeutics, Garland J. Scott, reported selling 13,000 shares of common stock for a total of $606,719. The shares were sold on 2026-10-01 at an average price of $46.6707 per share, and following this transaction, the reporting person no longer directly owns common stock in the company.

Read original source

ELVN company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.